niraparib 100 MG (as niraparib tosylate monohydrate 159.3 MG) Oral Tablet

RxCUI: 2637449
RxNorm name: niraparib 100 MG (as niraparib tosylate monohydrate 159.3 MG) Oral Tablet
Display name: niraparib 100 MG (as niraparib tosylate monohydrate 159.3 MG) Oral Tablet
Full name: niraparib 100 MG (as niraparib tosylate monohydrate 159.3 MG) Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ZEJULA	NIRAPARIB	GlaxoSmithKline LLC	b7f675e2-159c-490c-b6f4-3f16d9492b7d	2026-03-27	Warnings, Adverse reactions	Exact identifier rxcui: 2637449

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
b7f675e2-159c-490c-b6f4-3f16d9492b7d	niraparib 100 MG (as niraparib tosylate monohydrate 159.3 MG) Oral Tablet	SY	9	These highlights do not include all the information needed to use ZEJULA safely and effectively. See full prescribing information for ZEJULA. ZEJULA (niraparib) tablets, for oral use Initial U.S. Approval: 2017	20260327
b7f675e2-159c-490c-b6f4-3f16d9492b7d	niraparib 100 MG Oral Tablet	PSN	9	These highlights do not include all the information needed to use ZEJULA safely and effectively. See full prescribing information for ZEJULA. ZEJULA (niraparib) tablets, for oral use Initial U.S. Approval: 2017	20260327
b7f675e2-159c-490c-b6f4-3f16d9492b7d	niraparib 100 MG Oral Tablet	SCD	9	These highlights do not include all the information needed to use ZEJULA safely and effectively. See full prescribing information for ZEJULA. ZEJULA (niraparib) tablets, for oral use Initial U.S. Approval: 2017	20260327